{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:24:54Z","timestamp":1793121894989,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ymgme.2022.10.004","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T13:52:40Z","timestamp":1666014760000},"page":"309-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Intravenous 2-hydroxypropyl-\u03b2-cyclodextrin (Trappsol\u00ae Cyclo\u2122) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and peripheral tissues in adult subjects with Niemann-Pick Disease Type C1: Results of a phase 1 trial"],"prefix":"10.1016","volume":"137","author":[{"given":"Caroline","family":"Hastings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hrynkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2022.10.004_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/gim.2015.25","article-title":"High incidence of unrecognized visceral\/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets","volume":"18","author":"Wassif","year":"2016","journal-title":"Genet Med."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/CPJ.0000000000000399","article-title":"Recommendations for the detection and diagnosis of Niemann-Pick disease type C: an update","volume":"7","author":"Patterson","year":"2017","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2009.06.008","article-title":"Recommendations on the diagnosis and management of Niemann-Pick disease type C","volume":"98","author":"N.-C.G.W. Group","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0030","first-page":"1109","article-title":"The complexity of a monogenic neurodegenerative disease: more than two decades of therapeutic driven research into Niemann-Pick type C disease","volume":"2019","author":"Hammond","year":"1864","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ymgme.2022.10.004_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jbior.2018.08.001","article-title":"Niemann-Pick type C disease: the atypical sphingolipidosis","volume":"70","author":"Newton","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10255","article-title":"Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1","volume":"22","author":"Park","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jnc.14895","article-title":"Niemann-Pick type C disease: cellular pathology and pharmacotherapy","volume":"153","author":"Wheeler","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0050","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2022.10.004_bb0055","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1212\/01.wnl.0000345040.01917.9d","article-title":"Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem, and biochemical deficits","volume":"72","author":"Abel","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126600","article-title":"Neurodegeneration in Niemann-Pick Type C disease: an updated review on pharmacological and non-pharmacological approaches to counteract brain and cognitive impairment","volume":"22","author":"Cariati","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0065","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/jnnp.2005.086785","article-title":"Niemann-Pick type C disease in a 68-year-old patient","volume":"77","author":"Trendelenburg","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2022.10.004_bb0070","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s11033-020-05308-7","article-title":"New variants in Spanish Niemann-Pick type c disease patients","volume":"47","author":"Lopez de Frutos","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2021.06.011","article-title":"Estimating the prevalence of Niemann-Pick disease type C (NPC) in the United States","author":"Burton","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12883-015-0511-1","article-title":"Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database","volume":"15","author":"Imrie","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0090","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jimd.12245","article-title":"Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: a large retrospective observational study","volume":"43","author":"Patterson","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0095","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10545-011-9368-7","article-title":"Gastrointestinal disturbances and their management in miglustat-treated patients","volume":"34","author":"Belmatoug","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0100","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1177\/0883073812464526","article-title":"Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series","volume":"28","author":"Karimzadeh","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0110","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2022.10.004_bb0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/clp.12.31","article-title":"Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease","volume":"7","author":"Liu","year":"2012","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","article-title":"Genetic variations and treatments that affect the lifespan of the NPC1 mouse","volume":"49","author":"Liu","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0135","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/PDR.0b013e3181ee4dd2","article-title":"Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life","volume":"68","author":"Ramirez","year":"2010","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13023-019-1207-1","article-title":"Expanded access with intravenous hydroxypropyl-beta-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis","volume":"14","author":"Hastings","year":"2019","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","article-title":"Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C","volume":"153B","author":"Yanjanin","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0155","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"A. World Medical","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7863\/ultra.33.2.197","article-title":"Shear wave elastography for evaluation of liver fibrosis","volume":"33","author":"Ferraioli","year":"2014","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0165","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1194\/jlr.M000257","article-title":"Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid","volume":"51","author":"Liu","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0170","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1194\/jlr.M013789","article-title":"Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations","volume":"52","author":"Ramirez","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0175","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1523\/JNEUROSCI.1317-11.2011","article-title":"Unesterified cholesterol accumulation in late endosomes\/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment","volume":"31","author":"Aqul","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0180","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1074\/jbc.R100057200","article-title":"Control of cholesterol turnover in the mouse","volume":"277","author":"Dietschy","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0185","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1074\/jbc.M111.326405","article-title":"Normalization of cholesterol homeostasis by 2-hydroxypropyl-beta-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice","volume":"287","author":"Peake","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0190","series-title":"Ara Parseghian Scientific Conference on Niemann-Pick Type C Research","article-title":"Clinical experience and biomarker assessment with intravenous and intrathecal infusions of hydroxypropyl-\u03b2-cyclodextrin in identical twin patients with Niemann-Pick Type C disease","author":"Hastings","year":"2011"},{"key":"10.1016\/j.ymgme.2022.10.004_bb0195","article-title":"Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency","volume":"28","author":"Breilyn","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0200","doi-asserted-by":"crossref","first-page":"276ra26","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0205","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/hmg\/ddab194","article-title":"Transcriptome of HPbetaCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics","volume":"30","author":"Rodriguez-Gil","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0210","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00018-020-03706-5","article-title":"Cerebrospinal fluid outflow: a review of the historical and contemporary evidence for arachnoid villi, perineural routes, and dural lymphatics","volume":"78","author":"Proulx","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0215","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-2275(20)33390-3","article-title":"Comparison of the capacity of beta-cyclodextrin derivatives and cyclophanes to shuttle cholesterol between cells and serum lipoproteins","volume":"40","author":"Christian","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0220","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1194\/jlr.D300036-JLR200","article-title":"Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry","volume":"45","author":"Burkard","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0225","first-page":"45","article-title":"Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C","volume":"3","author":"Mattsson","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0230","series-title":"Update on Safety and Efficacy Results for Phase I\/II trial of Trappsol\u00ae Cyclo\u2122 Hydroxypropyl Betacyclodextrin Administered Intravenously in Subjects with Niemann-Pick type C1 Disease. Poster #209. in WORLDSymposium","author":"Raiman","year":"2021"},{"key":"10.1016\/j.ymgme.2022.10.004_bb0235","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10545-012-9583-x","article-title":"Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability","volume":"36","author":"Pontikis","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0240","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053280","article-title":"Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-beta-cyclodextrin","volume":"7","author":"Crumling","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2022.10.004_bb0250","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12640-020-00252-7","article-title":"2-hydroxypropyl-beta-cyclodextrin ototoxicity in adult rats: rapid onset and massive destruction of both inner and outer hair cells above a critical dose","volume":"38","author":"Liu","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0255","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0260","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2017.12.014","article-title":"Long-term treatment of Niemann-Pick type C1 disease with intrathecal 2-hydroxypropyl-beta-cyclodextrin","volume":"80","author":"Berry-Kravis","year":"2018","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2022.10.004_bb0265","article-title":"A phase 1\/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-beta-cyclodextrin for acute liver disease in infants with Niemann-Pick C1","volume":"28","author":"Reynolds","year":"2021","journal-title":"Mol. Genet. Metab. Rep."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922200419X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922200419X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:52:39Z","timestamp":1761090759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671922200419X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S109671922200419X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.10.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous 2-hydroxypropyl-\u03b2-cyclodextrin (Trappsol\u00ae Cyclo\u2122) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and peripheral tissues in adult subjects with Niemann-Pick Disease Type C1: Results of a phase 1 trial","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}